Is Novavax's COVID-19 Vaccine Superior to the mRNA Vaccines?

Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) have seized an early lead in vaccine distribution in the United States. Is it too late for that underdog biotech Novavax (NASDAQ: NVAX) to win market share? Or does it actually have some advantages in the rest of the world?

Motley Fool healthcare and cannabis bureau chief Corinne Cardina and Fool.com writer Taylor Carmichael talk about the similarities and differences between the COVID-19 vaccines. This Fool Live segment was recorded on June 18.

Continue reading

Source Fool.com